# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096411
Filing Date
2024-08-13
Accepted
2024-08-13 17:03:24
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rphm-20240630.htm iXBRL | 10-Q | 1551292
2 | EX-10.2 | rphm-ex10_2.htm | EX-10.2 | 48518
3 | EX-10.3 | rphm-ex10_3.htm | EX-10.3 | 52952
4 | EX-10.4 | rphm-ex10_4.htm | EX-10.4 | 50357
5 | EX-10.5 | rphm-ex10_5.htm | EX-10.5 | 48126
6 | EX-31.1 | rphm-ex31_1.htm | EX-31.1 | 16541
7 | EX-31.2 | rphm-ex31_2.htm | EX-31.2 | 16328
8 | EX-32.1 | rphm-ex32_1.htm | EX-32.1 | 14726
9 | GRAPHIC | img28451501_0.jpg | GRAPHIC | 11204
| Complete submission text file | 0000950170-24-096411.txt |  | 6493648

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rphm-20240630.xsd | EX-101.SCH | 1016809
68 | EXTRACTED XBRL INSTANCE DOCUMENT | rphm-20240630_htm.xml | XML | 939041

Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 241202743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)